• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

特刊：胶质母细胞瘤辅助治疗的主要挑战

Special Issue: Principal Challenges in the Adjuvant Treatment of Glioblastoma.

作者信息

Halatsch Marc-Eric

机构信息

Department of Neurosurgery, Cantonal Hospital of Winterthur, CH-8400 Winterthur, Switzerland.

出版信息

Biomedicines. 2023 Jul 3;11(7):1881. doi: 10.3390/biomedicines11071881.

DOI:10.3390/biomedicines11071881
PMID:37509520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10377107/
Abstract

Despite advances in local treatments, such as supramaximal resection (even in eloquent locations [...].

摘要

尽管在局部治疗方面取得了进展，如超最大限度切除（即使在功能区位置[...]。

相似文献

1
Special Issue: Principal Challenges in the Adjuvant Treatment of Glioblastoma.特刊：胶质母细胞瘤辅助治疗的主要挑战
Biomedicines. 2023 Jul 3;11(7):1881. doi: 10.3390/biomedicines11071881.
2
Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.肺叶切除术治疗胶质母细胞瘤的生存获益：向激进的超最大限度切除术发展。
J Neurooncol. 2020 Jul;148(3):501-508. doi: 10.1007/s11060-020-03541-5. Epub 2020 Jul 5.
3
Risk factors for glioblastoma therapy associated complications.胶质母细胞瘤治疗相关并发症的危险因素。
Clin Neurol Neurosurg. 2015 Jul;134:55-9. doi: 10.1016/j.clineuro.2015.01.006. Epub 2015 Jan 9.
4
Supramaximal resection: A systematic review of its safety, efficacy and feasibility in glioblastoma.超最大切除：胶质母细胞瘤中安全性、有效性和可行性的系统评价。
J Clin Neurosci. 2020 Feb;72:328-334. doi: 10.1016/j.jocn.2019.12.021. Epub 2019 Dec 18.
5
T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.通过清醒开颅手术实施的T2液体衰减反转恢复序列切除术治疗累及脑功能区的胶质母细胞瘤及其临床结果
World Neurosurg. 2020 Mar;135:e738-e747. doi: 10.1016/j.wneu.2019.12.130. Epub 2019 Dec 30.
6
Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study.清醒开颅术与无手术辅助的全麻开颅术治疗功能区幕上胶质母细胞瘤的回顾性匹配病例对照研究。
Acta Neurochir (Wien). 2019 Feb;161(2):307-315. doi: 10.1007/s00701-018-03788-y. Epub 2019 Jan 7.
7
Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.清醒开颅术治疗语言区脑胶质瘤（GLIOMAP）的效果：一项国际多中心队列研究的倾向评分匹配分析。
Lancet Oncol. 2022 Jun;23(6):802-817. doi: 10.1016/S1470-2045(22)00213-3. Epub 2022 May 12.
8
Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome.5-氨基乙酰丙酸（5-ALA）引导下对毗邻运动功能区的胶质母细胞瘤进行切除术中的单极标测：切除率及神经功能结果评估
Neurosurg Focus. 2014 Dec;37(6):E16. doi: 10.3171/2014.10.FOCUS14524.
9
The Merits of Awake Craniotomy for Glioblastoma in the Left Hemispheric Eloquent Area: One Institution Experience.《左侧语言功能区脑胶质瘤行清醒开颅术的优势：单中心经验》。
Clin Neurol Neurosurg. 2021 Jan;200:106343. doi: 10.1016/j.clineuro.2020.106343. Epub 2020 Nov 2.
10
What surgical approach for left-sided eloquent glioblastoma: biopsy, resection under general anesthesia or awake craniotomy?左侧功能区高级别胶质瘤采用何种手术方法：活检、全麻下切除还是唤醒开颅术？
J Neurooncol. 2022 Nov;160(2):445-454. doi: 10.1007/s11060-022-04163-9. Epub 2022 Nov 3.

本文引用的文献

1
EGFR, the Lazarus target for precision oncology in glioblastoma.表皮生长因子受体（EGFR），是胶质母细胞瘤精准肿瘤学的“拉撒路”靶点。
Neuro Oncol. 2022 Dec 1;24(12):2035-2062. doi: 10.1093/neuonc/noac204.
2
Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.新诊断的左侧功能区胶质母细胞瘤的根治性超全切除：与全切除相比的安全性及生存改善情况
J Neurosurg. 2022 May 27;138(1):62-69. doi: 10.3171/2022.3.JNS212399. Print 2023 Jan 1.
3
Emerging therapies for glioblastoma: current state and future directions.胶质母细胞瘤的新兴疗法：现状与未来方向。
J Exp Clin Cancer Res. 2022 Apr 15;41(1):142. doi: 10.1186/s13046-022-02349-7.
4
In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma.胶质母细胞瘤中药物重新利用方法CUSP9v3的体外及临床同情用药经验
Pharmaceuticals (Basel). 2021 Nov 29;14(12):1241. doi: 10.3390/ph14121241.
5
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.一项将9种重新利用的药物与替莫唑胺联合用于治疗复发性胶质母细胞瘤的Ib/IIa期试验：CUSP9v3
Neurooncol Adv. 2021 Jun 24;3(1):vdab075. doi: 10.1093/noajnl/vdab075. eCollection 2021 Jan-Dec.
6
Impact of F-FET PET/MRI on Clinical Management of Brain Tumor Patients.F-FET PET/MRI 对脑肿瘤患者临床管理的影响。
J Nucl Med. 2022 Apr;63(4):522-527. doi: 10.2967/jnumed.121.262051. Epub 2021 Aug 5.
7
Haloperidol Induced Cell Cycle Arrest and Apoptosis in Glioblastoma Cells.氟哌啶醇诱导胶质母细胞瘤细胞的细胞周期阻滞和凋亡。
Biomedicines. 2020 Dec 11;8(12):595. doi: 10.3390/biomedicines8120595.
8
Considering the Experimental use of Temozolomide in Glioblastoma Research.关于替莫唑胺在胶质母细胞瘤研究中的实验性应用。
Biomedicines. 2020 Jun 4;8(6):151. doi: 10.3390/biomedicines8060151.
9
Anti-epidermal growth factor receptor therapy for glioblastoma in adults.成人胶质母细胞瘤的抗表皮生长因子受体治疗
Cochrane Database Syst Rev. 2020 May 12;5(5):CD013238. doi: 10.1002/14651858.CD013238.pub2.
10
Comment in Response to "Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina".对“B. Kaina所著《替莫唑胺在胶质母细胞瘤治疗中的作用：细胞凋亡、衰老和自噬等》”的回应评论
Biomedicines. 2020 Apr 20;8(4):93. doi: 10.3390/biomedicines8040093.